Table 1. Baseline characteristics.
| Variable (N not-missing (% not-missing)) Cohort N = 72,683 |
Summary statistics |
|---|---|
| Primary outcome event (100%) |
11,616 (16%) |
| Followup years (mean (sd)) (100%) |
7.00 (4.01) |
| Age at enrollment (mean (sd)) (100%) |
52.84 (8.74) |
| Male (%) (100%) |
70,377 (96.8) |
| Race (%) (66,613 (91.65%)) |
|
| WHITE | 35,216 (52.9%) |
| BLACK OR AFRICAN AMERICAN | 27,081 (40.7%) |
| HISPANIC | 3,101 (4.7%) |
| OTHER | 1,215 (1.8%) |
| Albumin g/dl (mean (sd)) (69,982 (96.28%)) |
3.96 (0.46) |
| Alkaline phosphatase U/L (mean (sd)) (71,530 (98.41%)) |
86.11 (38.01) |
| ALT U/L (mean (sd)) (70,422 (96.89%)) |
61.64 (58.14) |
| APRI (mean (sd)) (100%) |
0.62 (0.55) |
| AST U/L (mean (sd)) (100%) |
49.94 (32.64) |
| Bilirubin mg/dl (mean (sd)) (72,115 (99.22%)) |
0.69 (0.41) |
| Body-mass-index (mean (sd)) (67,317 (92.62%)) |
27.17 (5.32) |
| Creatinine mg/dl (mean (sd)) (71,427 (98.27%)) |
1.08 (0.87) |
| INR (mean (sd)) (41,423 (56.99%)) |
1.06 (0.30) |
| Platelet count 1000/uL (mean (sd)) (100%) |
233.02 (74.88) |
| Sodium mmol/L (mean (sd)) (72,271 (99.43%)) |
138.85 (3.24) |